Biotech Stocks At 52-Week Highs - XNCR, COAG, MNPR, SOPH, ACRSrttnews·2 days ago, 02:45 AMMNPR-6.03%SOPH-5.47%
Aclaris publishes corporate presentation outlining inflammatory and immunology pipeline, 2026 clinical catalystsPUBT·Jul 15 at 12:38 PMACRS-2.49%
SL Science Holding, Alamos Gold And Other Big Stocks Moving Lower In Monday’s Pre-Market Sessionbenzinga_article·Jun 22 at 07:02 AMACRS-2.49%HMY-2.46%
3 Penny Stocks Under $5 Backed by Real Revenue GrowthMarket Beat·Jun 20 at 08:20 AMGRAB-1.49%URG-0.77%
Aclaris Therapeutics Maps Busy Pipeline Calendar, Plans Phase 2 Asthma Trial for ATI-052Market Beat·Jun 4 at 02:02 PMACRS-2.49%
This Piper Sandler Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations From Tuesdaybenzinga_article·Jun 3 at 08:13 AMACRS-2.49%ORN-1.75%
Aclaris Therapeutics, Inc. Stock 12‑Month Price Target Raised to $10.2, Implies 126% UpsideTradingView·May 23 at 05:20 PMACRS-2.49%BIB+1.68%
Aclaris Therap | 10-Q: FY2026 Q1 Revenue Beats Estimate at USD 1.996 MEarnings Watch·May 7 at 04:06 PMACRS-2.49%
Aclaris Therapeutics (ACRS) Gets a Buy from Craig-HallumTip Ranks·May 7 at 08:55 AMACRS-2.49%LABU+4.00%
Aclaris Therap | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 1.996 MEarnings Watch·May 7 at 06:18 AMACRS-2.49%
